drugset / Trial / NCT01536314

Prophylaxis of Neuropathic Pain by mémantine

NCT01536314 ↗

Phase 3 Completed 43 enrolled University Hospital, Clermont-Ferrand
NaSingle-groupOpen-labelPrevention

Summary

The aim of this study is to evaluate if memantine administered during 4 weeks beginning 2 weeks before surgery induces a decrease of painful intensity 3 months after surgery, compared to placebo group.

Timeline

Start
2012-02
Primary completion
2013-11
Completion
2013-11

Outcome

Met primary endpoint

paper Compared with placebo, patients receiving memantine showed at three months a significant difference in post-mastectomy pain intensity PMID 27050431 ↗

paper This study shows for the first time the beneficial effect of memantine to prevent post-mastectomy pain development PMID 27050431 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 5 mg —
Subject Memantine Unknown 20 mg —

Indications